Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
PraxisPro raises $6M seed from AlleyCorp to coach medical sales reps

From TechCrunch

By Dominic-Madori Davis

January 21, 2026

PraxisPro raises $6M seed from AlleyCorp to coach medical sales reps

PraxisPro raises $6M seed from AlleyCorp to coach medical sales reps

It all began in sales. That’s where Cam Badger got his start, at a pharmaceutical company. He expected to find structure and mentorship on the job but instead found “fragmented training, inconsistent coaching, and no real way to scale learning in a meaningful way,” he told TechCrunch. 

He spent four years as a sales rep, then a sales trainer, and then worked for a medical startup where he met Dr. Benny Alouf. The two lamented about how awful many sales reps were at life science companies like pharma businesses, medical device startups, and so forth. The duo, alongside Bhrugu Giri, decided to try and fix this, launching PraxisPro, a sales coaching platform specifically targeted at medical fields.

He believes that better salespeople will help get more treatments into doctors’ hands, which will ultimately help their patients.

“When commercial interactions with healthcare providers are ineffective, patients don’t get a fair shot at therapies that could meaningfully change their lives,” Badger, the company’s CEO, said. 

PraxisPro launched in 2023, though its first product was not released until 2025. The company announced on Wednesday a $6 million seed round led by AlleyCorp. Others in the round include Flybridge, South Loop Ventures, and Zeal Capital Partners. 

PraxisPro is a standalone platform that can also be integrated into enterprise software. It develops small language models trained on life science data to help each company navigate the nuances and context needed to interact with healthcare providers. From there, the company has created an AI agent that helps the commercial sales team practice their communication skills before engaging with customers. 

Badger said communication is critical in medical sales. So many teams are worried about staying compliant, as each company is responsible for ensuring sales messaging complies with legal frameworks. Aside from helping train sales reps to stay compliant, PraxisPro also hopes to help better educate them to communicate patient needs with healthcare providers. 

Right now, a salesperson may have 15 interactions with a healthcare provider as part of the sales process. PraxisPro has a conversational AI feature that lets sales reps practice and plan these interactions and be better prepared for what the discussion usually entails, including any pushback that might come up. 

There are other AI role-playing tools (like Quantified and SmartWinnr), but Badger says his is different because his company is trained on smaller datasets and specifically focuses on the life sciences sector. The fresh capital will be used toward research and development, he said.

In many ways, this was the tool he wished he had when he was still working as a sales rep all those years ago. He struggled, he said, and almost lost his job, but managed to work his way up to become one of the company’s top performers. Now, he wants to give others a hand. 

“If we can give commercial teams the ability to prepare, practice, and engage at a higher level, consistently and responsibly, then we’re not just improving commercial operations, but we’re helping ensure that innovative therapies reach the patients who need them most,” he said. 

This article was updated to clarify the name of the co-founder.

View original article on techcrunch.com

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Siro lands $50M to expand its AI-powered coaching for sales reps

Siro lands $50M to expand its AI-powered coaching for sales reps

A startup called Siro has raised $50 million to expand its AI-powered coaching app for sales reps.

May 21, 2025

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

11x.ai, a developer of AI sales reps, has raised $50M Series B led by A16Z, sources say

11x.ai, a developer of AI sales reps, has raised $50M Series B led by A16Z, sources say

11x.ai, a startup that develops AI-powered sales development bots, has secured roughly $50 million in Series B funding, TechCrunch has learned. The new round was led by Andreessen Horowitz, valuing the company at around $350 million, multiple sources told TechCrunch. The recent deal follows the company’s $24 million Series A, which was led by Benchmark with the participation of other investors including 20VC, Project A, Lux Capital, and SV Angel. While 11x.ai announced its Series A round earlie

Sep 30, 2024

Former Founders Fund VC Sam Blond launches AI sales startup to upend Salesforce

Former Founders Fund VC Sam Blond launches AI sales startup to upend Salesforce

The startup, Monaco, has come out of stealth as an AI-native all-in-one CRM plus more system backed by names like the Collison brothers and Garry Tan.

Feb 11, 2026

Most Recent

Neil Rimer thinks the AI money is coming back out

Neil Rimer thinks the AI money is coming back out

Neil Rimer, the venture capitalist who co-founded Index Ventures, predicts the historic wealth AI is generating in Silicon Valley will have to be redistributed, voluntarily or involuntarily.

Jul 17, 2026

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks hits $188B valuation, extending its run as AI’s favorite second act

Databricks has remade its image into an AI company and has published research on the cost savings of open weight AI models for coding.

Jul 17, 2026

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

Nuclear startup Valar Atomics in talks to raise new funding at $6B valuation

The potential deal highlights a growing trend of complex, multi-stage funding rounds that mask true entry prices.

Jul 17, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister, who demonstrated cool analysis in the Founders Fund YouTube series "Mafia," has joined the firm as a partner.

Jul 16, 2026

Similar Posts

Siro lands $50M to expand its AI-powered coaching for sales reps

Siro lands $50M to expand its AI-powered coaching for sales reps

A startup called Siro has raised $50 million to expand its AI-powered coaching app for sales reps.

May 21, 2025

Hippocratic is building a large language model for healthcare

Hippocratic is building a large language model for healthcare

AI, specifically generative AI, has the potential to transform healthcare. At least, that sales pitch from Hippocratic Health, which emerged from stealth today with a whopping $50 million in seed financing behind it and a valuation in the “triple digit millions.” The tranche, co-led by General Catalyst and Andreessen Horowitz, is a big vote of […]

May 16, 2023

11x.ai, a developer of AI sales reps, has raised $50M Series B led by A16Z, sources say

11x.ai, a developer of AI sales reps, has raised $50M Series B led by A16Z, sources say

11x.ai, a startup that develops AI-powered sales development bots, has secured roughly $50 million in Series B funding, TechCrunch has learned. The new round was led by Andreessen Horowitz, valuing the company at around $350 million, multiple sources told TechCrunch. The recent deal follows the company’s $24 million Series A, which was led by Benchmark with the participation of other investors including 20VC, Project A, Lux Capital, and SV Angel. While 11x.ai announced its Series A round earlie

Sep 30, 2024

Former Founders Fund VC Sam Blond launches AI sales startup to upend Salesforce

Former Founders Fund VC Sam Blond launches AI sales startup to upend Salesforce

The startup, Monaco, has come out of stealth as an AI-native all-in-one CRM plus more system backed by names like the Collison brothers and Garry Tan.

Feb 11, 2026